UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 4, 2012
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
| UTAH | 87-0342734 |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |
| | |
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On May 4, 2012 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:
| Elected Kevin L. Cornwell as a director of the Company: |
| For | 2,723,871 | Withheld | 52,884 | Broker Non-Votes | 462,822 |
| | | | | | |
| Elected Paul O. Richins as a director of the Company: |
| For | 2,698,468 | Withheld | 78,287 | Broker Non-Votes | 462,822 |
| | | | | | |
| Ratified the selection of Jones, Simkins P.C. as the Company’s independent public accounting firm for the year ended December 31, 2012: |
| For | 3,228,160 | Against | 5,177 | Abstentions | 6,240 |
| | | | | | |
| Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: |
| For | 2,731,595 | Against | 30,854 | Abstentions | 14,306 |
| | | | | | |
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | UTAH MEDICAL PRODUCTS, INC. |
| | REGISTRANT |
| | |
| | |
Date: 5/08/2012 | By: /s/ Kevin L. Cornwell |
| | Kevin L. Cornwell |
| | CEO |
